FTDI
First Trust Direct Indexing’s DexCom DXCM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,124
| Closed | -$612K | – | 265 |
|
|
2024
Q3 | $612K | Sell |
9,124
-3,897
| -30% | -$261K | 0.03% | 483 |
|
|
2024
Q2 | $1.48M | Buy |
13,021
+530
| +4% | +$60.1K | 0.09% | 226 |
|
|
2024
Q1 | $1.73M | Buy |
12,491
+2,571
| +26% | +$357K | 0.13% | 163 |
|
|
2023
Q4 | $1.23M | Buy |
9,920
+1,418
| +17% | +$176K | 0.11% | 207 |
|
|
2023
Q3 | $793K | Sell |
8,502
-887
| -9% | -$82.8K | 0.09% | 269 |
|
|
2023
Q2 | $1.21M | Buy |
9,389
+196
| +2% | +$25.2K | 0.13% | 171 |
|
|
2023
Q1 | $1.07M | Sell |
9,193
-374
| -4% | -$43.5K | 0.13% | 190 |
|
|
2022
Q4 | $1.08M | Sell |
9,567
-180
| -2% | -$20.4K | 0.14% | 180 |
|
|
2022
Q3 | $785K | Buy |
9,747
+883
| +10% | +$71.1K | 0.11% | 233 |
|
|
2022
Q2 | $661K | Buy |
8,864
+6,863
| +343% | +$512K | 0.09% | 281 |
|
|
2022
Q1 | $1.02M | Buy |
2,001
+86
| +4% | +$44K | 0.12% | 204 |
|
|
2021
Q4 | $1.03M | Sell |
1,915
-26
| -1% | -$14K | 0.13% | 183 |
|
|
2021
Q3 | $1.06M | Sell |
1,941
-358
| -16% | -$196K | 0.15% | 162 |
|
|
2021
Q2 | $982K | Buy |
2,299
+714
| +45% | +$305K | 0.15% | 178 |
|
|
2021
Q1 | $570K | Buy |
1,585
+63
| +4% | +$22.7K | 0.15% | 182 |
|
|
2020
Q4 | $563K | Buy |
+1,522
| New | +$563K | 0.15% | 167 |
|